Literature DB >> 34930780

Aire Controls Heterogeneity of Medullary Thymic Epithelial Cells for the Expression of Self-Antigens.

Hitoshi Nishijima1, Minoru Matsumoto1,2,3, Junko Morimoto1, Kazuyoshi Hosomichi4, Nobuko Akiyama5, Taishin Akiyama6, Takeshi Oya3, Koichi Tsuneyama2, Hideyuki Yoshida7, Mitsuru Matsumoto8.   

Abstract

The deficiency of Aire, a transcriptional regulator whose defect results in the development of autoimmunity, is associated with reduced expression of tissue-restricted self-Ags (TRAs) in medullary thymic epithelial cells (mTECs). Although the mechanisms underlying Aire-dependent expression of TRAs need to be explored, the physical identification of the target(s) of Aire has been hampered by the low and promiscuous expression of TRAs. We have tackled this issue by engineering mice with augmented Aire expression. Integration of the transcriptomic data from Aire-augmented and Aire-deficient mTECs revealed that a large proportion of so-called Aire-dependent genes, including those of TRAs, may not be direct transcriptional targets downstream of Aire. Rather, Aire induces TRA expression indirectly through controlling the heterogeneity of mTECs, as revealed by single-cell analyses. In contrast, Ccl25 emerged as a canonical target of Aire, and we verified this both in vitro and in vivo. Our approach has illuminated the Aire's primary targets while distinguishing them from the secondary targets.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34930780     DOI: 10.4049/jimmunol.2100692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  1 in total

1.  Development of organ-specific autoimmunity by dysregulated Aire expression.

Authors:  Hitoshi Nishijima; Mizuki Sugita; Natsuka Umezawa; Naoki Kimura; Hirokazu Sasaki; Hiroshi Kawano; Yasuhiko Nishioka; Minoru Matsumoto; Takeshi Oya; Koichi Tsuneyama; Junko Morimoto; Mitsuru Matsumoto
Journal:  Immunol Cell Biol       Date:  2022-04-09       Impact factor: 5.853

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.